These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27713199)

  • 1. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
    Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
    Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction.
    Saito T; Liu M; Binnie M; Sato M; Hwang D; Azad S; Machuca TN; Zamel R; Waddell TK; Cypel M; Keshavjee S
    Am J Transplant; 2014 Jun; 14(6):1425-32. PubMed ID: 24787265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
    Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lung allograft dysfunction: evolving practice.
    Vos R; Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation.
    Renaud-Picard B; Berra G; Hwang D; Huszti E; Miyamoto E; Berry GJ; Pal P; Juvet S; Keshavjee S; Martinu T
    J Heart Lung Transplant; 2024 Oct; 43(10):1701-1715. PubMed ID: 38663465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
    Snell GI; Paraskeva M; Westall GP
    Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
    Sato M
    Ann Transl Med; 2020 Mar; 8(6):418. PubMed ID: 32355862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lung allograft dysfunction phenotypes and treatment.
    Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
    J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
    DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
    Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
    Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
    Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.